Overview

Cabergoline Effect on Blood Sugar in Type 2 Diabetics

Status:
Unknown status
Trial end date:
2012-02-01
Target enrollment:
Participant gender:
Summary
Diabetic patients with poorly control blood sugar are prescribed cabergoline for 1 months and their blood glucose is evaluated.
Phase:
N/A
Details
Lead Sponsor:
Mashhad University of Medical Sciences
Treatments:
Cabergoline